Status:
WITHDRAWN
Ampicillin-sulbactam Resistant E.Coli at UPMC
Lead Sponsor:
University of Pittsburgh
Conditions:
Positive E Coli Infections
Eligibility:
All Genders
18+ years
Brief Summary
The information collected will optimize the management of patients with gram negative bacteremia. Approximately 300 patients with Gram negative bacteremia are cared for each year at UPMC-P. Published ...
Detailed Description
The information collected will optimize the management of patients with gram negative bacteremia. Approximately 300 patients with Gram negative bacteremia are cared for each year at UPMC-P. All sites ...
Eligibility Criteria
Inclusion
- All patients at the aforementioned institutions that have Gram negative bacteremia will be included in the study.
- Women with childbearing potential will also be included in this study. Since this is an observational study, no added risk is conferred to the woman or potential progeny. HIV serostatus will not be specifically investigated for participation in this study.
Exclusion
- None
Key Trial Info
Start Date :
February 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00619580
Start Date
February 1 2008
End Date
December 1 2014
Last Update
December 8 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UPMC
Pittsburgh, Pennsylvania, United States, 15213